Kanagawa, Japan

Ayumi Kaneda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Keio University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ayumi Kaneda. Retrieved from https://idiyas.com/inventor/ayumi-kaneda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ayumi Kaneda: Innovator in Pharmaceutical Compositions

Introduction

Ayumi Kaneda is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that target specific biological pathways.

Latest Patents

One of her notable patents is focused on pharmaceutical compositions that inhibit the expression of iNOS and COX-2 without affecting NF-κB. This innovative composition includes DTCM glutarimide as an effective ingredient, which helps in reducing nitric oxide (NO) and prostaglandin production. This patent showcases her commitment to advancing medical science and improving therapeutic options.

Career Highlights

Ayumi Kaneda is affiliated with Keio University, where she continues her research and development efforts. Her work has garnered attention for its potential applications in treating various conditions linked to inflammation and pain.

Collaborations

She has collaborated with esteemed colleagues such as Kazuo Umezawa and Yuichi Ishikawa, contributing to a rich environment of innovation and research.

Conclusion

Ayumi Kaneda's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions are paving the way for new treatments and enhancing our understanding of complex biological processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…